Cargando…

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective

The objective of the present study was to describe a new model of the cost-effectiveness of treatment of generalized anxiety disorder (GAD) and its application to a comparison of pregabalin versus venlafaxine extended-release (XR) from a Spanish healthcare perspective. Microsimulation techniques, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vera-Llonch, Montserrat, Dukes, Ellen, Rejas, Javier, Sofrygin, Oleg, Mychaskiw, Marko, Oster, Gerry
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816249/ https://www.ncbi.nlm.nih.gov/pubmed/19506926 http://dx.doi.org/10.1007/s10198-009-0160-7

Ejemplares similares

Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder
por: Berger, Ariel, et al.
Publicado: (2009)

A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal
por: Silva Miguel, Luís, et al.
Publicado: (2013)

Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database
por: Berger, Ariel, et al.
Publicado: (2014)

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity
por: Sicras‐Mainar, Antoni, et al.
Publicado: (2016)

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain
por: De Salas-Cansado, Marina, et al.
Publicado: (2012)

A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings
por: Navarro, Ana, et al.
Publicado: (2011)

Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
por: Álvarez, Enrique, et al.
Publicado: (2015)

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
por: Ruiz, Miguel A, et al.
Publicado: (2015)

Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy: A randomized, double-blind trial
por: Razazian, Nazanin, et al.
Publicado: (2014)

Pharmacoeconomic evaluation of venlafaxine compared with citalopram in generalized anxiety disorder
por: ZHANG, JINGJING, et al.
Publicado: (2013)

Pregabalin for the treatment of generalized anxiety disorder
por: Khallouk, A., et al.
Publicado: (2022)

Relationship of American Spinal Injury Association Impairment Scale Grade to Post-injury Hospitalization and Costs in Thoracic Spinal Cord Injury
por: Dukes, Ellen M, et al.
Publicado: (2018)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Facial Flushing Associated with Anxiety and Improved by Venlafaxine: A Case Report
por: Qiu, Yong, et al.
Publicado: (2022)

Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool
por: García-Campayo, Javier, et al.
Publicado: (2010)

Role of pregabalin in the treatment of generalized anxiety disorder
por: Baldwin, David S, et al.
Publicado: (2007)

Pregabalin for the treatment of generalized anxiety disorder: an update
por: Baldwin, David S, et al.
Publicado: (2013)

Determinants and predictors of the cost of COPD in primary care: A Spanish perspective
por: de Miguel Diez, Javier, et al.
Publicado: (2008)

The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice
por: García-Campayo, Javier, et al.
Publicado: (2012)

Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings
por: Saldaña, María Teresa, et al.
Publicado: (2009)

Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001)

Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013)

Kleptomania Induced by Venlafaxine
por: Sakurada, Kumi, et al.
Publicado: (2021)

Venlafaxine-induced hypoglycemia
por: Kobylianskii, Jane, et al.
Publicado: (2021)

FRI090 Patterns Of Triglyceride Testing And Results Over Time Among Patients With Diabetes And Severe Hypertriglyceridemia In US Clinical Practice
por: Kutrieb, Emily, et al.
Publicado: (2023)

Preparation and Characterisation of Mucoadhesive Nasal Gel of Venlafaxine Hydrochloride for Treatment of Anxiety Disorders
por: Basu, Shyamoshree, et al.
Publicado: (2012)

Venlafaxine-Induced Severe Sleep Bruxism in a Patient with Generalized Anxiety Disorder
por: Jose, Sam Padamadan
Publicado: (2015)

The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
por: Strawn, Jeffrey R, et al.
Publicado: (2007)

Reduction of Methylphenidate Induced Anxiety, Depression and Cognition Impairment by Various doses of Venlafaxine in Rat
por: Motaghinejad, Majid, et al.
Publicado: (2015)

PS86. Kleptomania - a side-effect induced by venlafaxine
por: Jukic, Vlado, et al.
Publicado: (2016)

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder
por: Sobocki, P, et al.
Publicado: (2008)

VENLAFAXINE - INDUCED ORTHOSTATIC HYPOTENSION
por: Duggal, Harpreet S., et al.
Publicado: (2001)

Venlafaxine in the treatment of panic disorder
por: Katzman, Martin A, et al.
Publicado: (2007)

Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010)

Venlafaxine-induced psychotic symptoms
por: Safeekh, A. T., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_q7j83lapv0tuhskglj160j8fhg